Draft qualification opinion on Cellular therapy module of the EBMT European Medicine Agency (EMA) releases their draft qualification opinion on the cellular therapy module of the EBMT registry for public consultation.
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.
Download pdf EMA report on CAR T-cell therapies workshop This report summarises observations made by the participants of the workshop organised by the EMA on February 9th 2018 on the use of registry data to support regulatory benefit-risk evaluations of CAR T-cell therapies and, in particular, post-authorisation follow-up.
Download pdf A new educational App helps support Graft-Versus-Host Disease Diagnosis and Scoring after Hematopoietic Cell Transplantation